Analysis | Samples | Factors | Units |
---|---|---|---|
Oxylipins analysis,Negative | S29A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S30A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S31A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S32A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S33A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S34A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S35A | Sample Type:Adipocyte | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S17A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S19A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S20A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S23A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S24A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S25A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S26A | Sample Type:Adipocyte | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S29C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S30C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S31C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S32C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S33C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S34C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S35C | Sample Type:Co-culture | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S17C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S19C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S20C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S23C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S24C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S25C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S26C | Sample Type:Co-culture | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S29B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S30B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S31B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S32B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S33B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S34B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S35B | Sample Type:Control | Timepoint:18 hours | Area % |
Oxylipins analysis,Negative | S17B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S19B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S20B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S23B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S24B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S25B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | S26B | Sample Type:Control | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | Media blank | Sample Type:Media blank | Timepoint:4 hours | Area % |
Oxylipins analysis,Negative | Blank media | Sample Type:Media blank | Timepoint:NA | Area % |
Ceramide analysis, Positive | S29A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S30A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S31A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S32A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S33A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S34A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S35A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S17A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S19A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S20A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S23A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S24A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S25A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S26A | Sample Type:Adipocyte | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S29C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S30C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S31C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S32C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S33C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S34C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S35C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S17C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S19C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S20C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S23C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S24C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S25C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S26C | Sample Type:Co-culture | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S29B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S30B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S31B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S32B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S33B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S34B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S35B | Sample Type:Control | Timepoint:18 hours | nM |
Ceramide analysis, Positive | S17B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S19B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S20B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S23B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S24B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S25B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | S26B | Sample Type:Control | Timepoint:4 hours | nM |
Ceramide analysis, Positive | Media blank | Sample Type:Media blank | Timepoint:4 hours | nM |
Ceramide analysis, Positive | Blank media | Sample Type:Media blank | Timepoint:NA | nM |
Endocannabinoid analysis, positive | S29A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S30A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S31A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S32A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S33A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S34A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S35A | Sample Type:Adipocyte | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S29C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S30C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S31C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S32C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S33C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S34C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S35C | Sample Type:Co-culture | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S29B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S30B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S31B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S32B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S33B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S34B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | S35B | Sample Type:Control | Timepoint:18 hours | nM |
Endocannabinoid analysis, positive | Blank media | Sample Type:Media blank | Timepoint:NA | nM |